Holen Sie sich die Stockscreener-App
70.48
2.56%
1.76
Vorhandelsmarkt:
72.15
1.67
+2.37%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Astrazeneca PLC Aktie (AZN) Neueste Nachrichten
What analysts say about AstraZeneca PLC Depositary Receipt stockExceptional return forecasts - Autocar Professional
AstraZeneca vows to spend US$50bil on US manufacturing boost - thestar.com.my
AstraZeneca Pledges Big Investment In US Manufacturing Amid Tariff Threats - insights.citeline.com
AstraZeneca commits $50 billion to US pharmaceutical manufacturing and R&D - BioProcess International
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - Benzinga
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy - Benzinga
AstraZeneca to invest $50 bn in the US as tariff threat looms - Yahoo.co
AstraZeneca to invest $50B in US to boost drug manufacturing and R&D - Proactive financial news
AstraZeneca’s Phase 2 Study on Trastuzumab Deruxtecan: A Potential Game-Changer in Cancer Treatment - TipRanks
AstraZeneca’s CORSAR Study: Unveiling Severe Asthma Insights in Russia - The Globe and Mail
AstraZeneca’s New Trial: A Step Forward in Liver Fibrosis Treatment? - TipRanks
Fear of tariffs? AstraZeneca calls $50 billion US investment a ‘deliberate choice’ - Euractiv
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer in COPD Treatment - TipRanks
AstraZeneca’s Tezepelumab Study: Potential Breakthrough in Asthma Treatment - TipRanks
AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures - TradingView
AstraZeneca picks Virginia for multibillion-dollar manufacturing site - Richmond Times-Dispatch
Lockheed Martin, AstraZeneca, DR Horton: Trending Tickers - Yahoo Finance
Astrazeneca, Phillip Morris & D.R. Horton earnings: Trending Tickers - Yahoo.co
AstraZeneca considers moving listing to US, the Times reports - Yahoo.co
AstraZeneca announces $50 billion US investment in manufacturing and R&D By Investing.com - Investing.com Australia
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D July 22, 2025 - James Sharp & Co.
AZN to invest $50bn in US, targets $80bn revenue by 2030 | AZN SEC FilingForm 6-K - Stock Titan
Global pharma companies do record deals with Chinese biotechs - Financial Times
Trending tickers: AstraZeneca, Verizon, Opendoor, Trump Media and Lindt & Spruengli - Yahoo.co
AstraZeneca unveils $50 billion US investment as pharma tariff threat looms - Reuters
Astra Pledges $50 Billion on US Manufacturing, Development - Bloomberg
AstraZeneca PLC (AZN)’s Datroway Wins FDA Nod for Lung Cancer Breakthrough - MSN
AstraZeneca announces $50bn US investment in manufacturing and R&D - Proactive financial news
AstraZeneca unveils plans for £37bn investment in US amid tariff threats - Yahoo.co
AstraZeneca to invest $50bn in the US amid fears it could quit Britain - The Telegraph
AstraZeneca pledges $50bn in US investment as Trump pharma tariffs loom - Financial Times
AstraZeneca Vows to Spend $50 Billion on US Manufacturing, Development - MSN
AstraZeneca to invest $50bn in US after Trump tariff threat - The Times
Astrazeneca plots huge $50bn US investment after ditching UK expansion plans - Yahoo.co
AstraZeneca says to invest $50 bn in the US - Yahoo.co
AstraZeneca To Invest $50bn In The US, New Virginia Manufacturing Site Planned - DirectorsTalk Interviews
AstraZeneca To Invest $50 Bln In U.S. By 2030 To Boost Medicine Production And Research - Nasdaq
AstraZeneca vows to spend $50 billion on US manufacturing, development - CNBC TV18
AstraZeneca grows US presence with $50B in spending plans - BioPharma Dive
AstraZeneca pledges $50 bln investment in US as pharma tariffs loom By Investing.com - Investing.com
AstraZeneca to invest $50B in US economy by 2030 - AOL.com
AstraZeneca to invest $50B in US by 2030 - breakingthenews.net
AstraZeneca to spend $50-billion to expand manufacturing, research capabilities in U.S. - The Globe and Mail
AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer - Yahoo Finance
AstraZeneca’s Observational SLE Study in Kazakhstan: Key Insights for Investors - TipRanks
AstraZeneca Plans Massive $50B US Investment: New Virginia Mega-Factory to Create Thousands of Jobs - Stock Titan
AstraZeneca’s Promising Pediatric SLE Study: Anifrolumab’s Potential Impact - TipRanks
AstraZeneca’s New Phase II Study: A Potential Breakthrough in Liver Cancer Treatment - TipRanks
AstraZeneca’s COPD Study: Potential Game-Changer for Cardiopulmonary Outcomes - TipRanks
AstraZeneca’s AIRSUPRA Study: A Potential Game-Changer in Asthma Treatment - TipRanks
What drives AstraZeneca PLC Depositary Receipt stock priceRapid wealth multiplication - Autocar Professional
AstraZeneca reports positive results from Tagrisso combo trial - Seeking Alpha
AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters - Stocktwits
AstraZeneca’s lung cancer drug shows improved survival with chemotherapy combo - Investing.com UK
Is it worth me buying more AstraZeneca shares at just over £13? - Yahoo.co
Is AstraZeneca PLC Depositary Receipt a good long term investmentUnrivaled growth potential - jammulinksnews.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):